|
Mercado cerrado -
Otros sitios de cotización
|
Variación 5 días | Varia. 1 de enero. | ||
| 741,29 USD | -0,74 % |
|
+3,19 % | +4,07 % |
| 12/12 | REGENERON PHARMACEUTICALS, INC. : Morgan Stanley da una recomendación neutral | ZM |
| 12/12 | El regulador europeo de salud recomienda la aprobación del medicamento semestral para el asma de GSK | RE |
Principales competidores
Añadir a una lista 0 seleccionado | Rentabilidad (Y) | Rentabilidad (Y+1) | Ratio PER (Y) | Ratio PBR (Y) | VE / Ventas (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 0,5 % | 0,53 % | 18.14x | 2.39x | 4.9x | 12.92x | 14.83x | 76,06 mil M | |
| 2,53 % | 2,75 % | 23.31x | 2.82x | 4.23x | 12.3x | 14.2x | 58,96 mil M | |
| -.--% | -.--% | 50.21x | 6.77x | 13.28x | 28.8x | 36.1x | 53,01 mil M | |
| 0,6 % | 0,62 % | 39.69x | 4.11x | 6.14x | 19.91x | 27.51x | 52,48 mil M | |
| -.--% | -.--% | 16.18x | 1.38x | 2.8x | 8.54x | 9.75x | 25,54 mil M | |
| -.--% | 0,02 % | 78.56x | 7.71x | 9.37x | 84.18x | 96.59x | 18,76 mil M | |
| -.--% | -.--% | 15.46x | 3.25x | 2.96x | 9.4x | 9.02x | 18,73 mil M | |
| -.--% | -.--% | -21.8x | - | 31.64x | -32.06x | -31.22x | 14,48 mil M | |
| -.--% | -.--% | -593.65x | 2.76x | 4.32x | 11.23x | 24.28x | 12,23 mil M | |
| -.--% | -.--% | -3.61x | 1.36x | 3.14x | -1.85x | -1.76x | 11,51 mil M | |
| -.--% | -.--% | -16.04x | - | 521.12x | -15.81x | -15.97x | 10,82 mil M | |
| -.--% | -.--% | 18.95x | 1.66x | 2.82x | 13.06x | 13.78x | 10,24 mil M | |
| 2,82 % | 1,83 % | 6.42x | 2.69x | 3.03x | 4.52x | 4.57x | 8926,62 M | |
| -.--% | -.--% | -260.95x | - | - | - | - | 8460,33 M | |
| 1,32 % | 1,86 % | 17.16x | 1.15x | 2.07x | 8.57x | 11.41x | 7731,07 M | |
| -.--% | -.--% | -39.08x | 164.46x | 11.7x | -48.06x | -42.48x | 7469,64 M | |
| -.--% | -.--% | 38.76x | - | 16.95x | 39.83x | 40.49x | 7094,24 M | |
| Promedio | 0,46 % | 0,45 % | -36,02x | 15,58x | 40,03x | 9,72x | 13,19x | 23,68 mil M | |
| Media ponderada por Capi. | 0,63 % | 0,66 % | 0,11x | 6,89x | 21,36x | 14,96x | 18,89x |
- Bolsa de valores
- Acciones
- Acción REGN
- Sector Regeneron Pharmaceuticals, Inc.
- Dividendos sectoriales
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
Seguir con la edición actual